Results 131 to 138 of about 377,194 (138)

Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting. [PDF]

J Gynecol Oncol
Termrungruanglert W, Khemapech N, Vasuratna A, Havanond P, Tantitamit T.   +4 more
europepmc   +1 more source

IAPSM's Position Paper on the Human Papilloma Virus (HPV) Vaccine for Adult Immunization in India. [PDF]

Indian J Community Med
Shetty RS, Nadda A, Tambe M, Raut A, Goel K, Rao CR, Mehta A, Bhardwaj P, Gupta M, Kamath VG.   +9 more
europepmc   +1 more source

Efficacy, effectiveness and immunogenicity of reduced HPV vaccination schedules: A review of available evidence. [PDF]

Can Commun Dis Rep
Montroy J, Salvadori MI, Forbes N, Dubey V, Almasri S, Jirovec A, Yan C, Gusic K, Stevens A, Young K, Tunis M.   +10 more
europepmc   +1 more source

A Comprehensive Evaluation of the HPV Neutralizing Antibodies in Guangzhou, China: A Comparative Study on Various HPV Vaccines. [PDF]

Vaccines (Basel)
Zha R, Liao C, Lin D, Zhao L, Chen Y, Yao L, Li X, Yi B, Li T, Xiao J, Hu Y, Chen Z, Guo C, Lu J, Lu J.   +14 more
europepmc   +1 more source

Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study. [PDF]

Lancet Reg Health West Pac
You T, Zhao X, Pan C, Gao M, Hu S, Liu Y, Zhang Y, Qiao Y, Zhao F, Jit M.   +9 more
europepmc   +1 more source

Infectious disease hospitalization after receipt of human papillomavirus vaccine: a nationwide register-based cohort study among Danish, Finnish, Norwegian, and Swedish girls. [PDF]

Eur J Epidemiol
Laake I, Feiring B, Gehrt L, Englund H, Lahdenkari M, Sørup S, Nieminen H, Trogstad L.   +7 more
europepmc   +1 more source

Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence.

J Pharm Bioallied Sci
Alqahtani AMM, Alshahrani MSS, Almajed E, Salamah RAB, Alqntash N, Biju AM, Meem MS, Pullishery F.   +7 more
europepmc   +1 more source